Drug Profile
LCB14 17nn
Alternative Names: LCB14-17nnLatest Information Update: 01 Apr 2022
Price :
$50
*
At a glance
- Originator Green Cross
- Developer GC Biopharma
- Class Antibodies; Antineoplastics; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer